Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are expecting strong growth driven by the continued https://lucanhj365249.csublogs.com/44224812/eli-lilly-s-q3-performance-an-in-depth-look